Dr Loubna Bouarfa is the founder and CEO of OKRA.ai – a leading artificial intelligence (AI) company for life sciences, that supports the industry in bringing the right drug to the right patient at speed.
Loubna, a member of the European Union High-Level Expert Group on AI, was in 2018 named an MIT Technology Review Top Innovator Under 35 and a Forbes Top 50 Women In Tech. In 2019 she accepted the CEO of the year award at the Cambridge Independent Science and Technology Awards, along with the Best Female-Led Startup at the StartUp Europe Awards. 2022 she has been selected as a European Young Leader (EYL40).
OKRA.ai began with our founder and CEO Dr Loubna Bouarfa, who has spent the last 15 years researching the field of AI and implementing it across healthcare. In 2007, Loubna applied her research to the operating table, predicting surgical errors in real-time – alerting surgeons to potential errors in order to prevent them. This paper has become the most cited study of its kind in the field of machine learning for surgical workflows and paved the way for her to make the move from research to entrepreneurship.
Loubna founded OKRA.ai in 2015 as a leading artificial intelligence (AI) company transforming life sciences operations through the use of AI solutions. OKRA.ai has created a state-of-the-art, AI solution suite that compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics.
We are incredibly proud to be based in one of the top tech cities in Europe. Cambridge is a hub of creativity, and innovativeness and rich in cognitive diversity, ideal for the cutting-edge work we do here at OKRA.ai.